Nordrhein-Westfalen
Universitätsklinikum Münster - Medizinische Klinik A
Albert-Schweitzer-Campus 1, Gebäude A1
D-48149 Münster
D-48149 Münster
Leitung: Univ.-Prof. Dr. med. Georg Lenz
Studien
-
INTEGRATE ATMP
-
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies (LONGSAFE)
-
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients (DALY 2-EU)
-
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
-
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Studien
-
INTEGRATE ATMP
-
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies (LONGSAFE)
-
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients (DALY 2-EU)
-
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
-
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells